MyFinsight
Home
Blog
About
Back
Cash Flow
Palomino Laboratories Inc. (PALX)
Palomino Laboratories Inc. (PALX)
source: myfinsight.com
Proceeds from sale of
common stock and...
$14,820,975
Net cash provided by
financing activities
$14,850,975
Net increase in cash
and cash...
$12,788,152
Canceled cashflow
$2,062,823
Stock-based compensation
related to employees and...
$100,528
Accounts payable
$75,316
Accrued expenses and
other liabilities
$62,723
Depreciation expense
$12,450
Change in right of use
and lease liability
$550
Net cash used in
operating activities
-$1,121,507
Net cash used in
investing activities
-$941,316
Canceled cashflow
$251,567
Net loss
-$1,365,034
Purchase of property and
equipment
$941,316
Prepaids and other assets
$8,040
Back